Conexeu Sciences Inc.(CNXU)

Biotechnology · Reno, NV

$3.66+0.54 (+17.42%)

Delayed quote: Oct 6, 2026, 2:10 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T18:11:35.747Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:11:35.747Z.

Quote observation: 2026-10-06T18:10:17.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 98,031,810
Total debt: N/A
Cash: N/A
TTM free cash flow: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNXU EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

CNXU Competitors' EV/FCF Ratio

CNXU

Conexeu Sciences Inc.

Current

Market Cap

$98.03M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs CNXU

Market Cap

$99.23M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIST

Milestone Pharmaceuticals Inc.

vs CNXU

Market Cap

$97.38M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KRRO

Korro Bio, Inc.

vs CNXU

Market Cap

$97.14M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs CNXU

Market Cap

$102.64M

EV/FCF Ratio

19.52x

TTM Avg

87.97x

3Y Avg

49.68x

5Y Avg

56.25x

OKUR

OnKure Therapeutics, Inc.

vs CNXU

Market Cap

$103.06M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLYX

Polaryx Therapeutics, Inc. Common Stock

vs CNXU

Market Cap

$104.18M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BDTX

Black Diamond Therapeutics, Inc.

vs CNXU

Market Cap

$103.72M

EV/FCF Ratio

N/A

TTM Avg

7.65x

3Y Avg

7.65x

5Y Avg

7.65x

ANIX

Anixa Biosciences, Inc.

vs CNXU

Market Cap

$104.96M

EV/FCF Ratio

N/A

TTM Avg

15.12x

3Y Avg

15.12x

5Y Avg

15.12x

Definitive Healthcare Corp.

vs CNXU

Market Cap

$104.89M

EV/FCF Ratio

3.54x

TTM Avg

5.56x

3Y Avg

15.97x

5Y Avg

36.28x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Conexeu Sciences Inc. (CNXU)	$98.03M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$99.23M	N/A	N/A	N/A	N/A
Milestone Pharmaceuticals Inc. (MIST)vs ›	$97.38M	N/A	N/A	N/A	N/A
Korro Bio, Inc. (KRRO)vs ›	$97.14M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.64M	19.52x	87.97x	49.68x	56.25x
OnKure Therapeutics, Inc. (OKUR)vs ›	$103.06M	N/A	N/A	N/A	N/A
Polaryx Therapeutics, Inc. Common Stock (PLYX)vs ›	$104.18M	N/A	N/A	N/A	N/A
Black Diamond Therapeutics, Inc. (BDTX)vs ›	$103.72M	N/A	7.65x	7.65x	7.65x
Anixa Biosciences, Inc. (ANIX)vs ›	$104.96M	N/A	15.12x	15.12x	15.12x
Definitive Healthcare Corp. (DH)vs ›	$104.89M	3.54x	5.56x	15.97x	36.28x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

CNXU EV/FCF Ratio Metrics

CNXU Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics